Bayer gives almost £26,000 to charity after big fundraising day
Reading, 21 November, 2017 - The cash was raised after 226 people from Bayer’s General Medicine division took part in a swim-cycle-run ‘Try-Athlon’ in July – followed by a big day of fundraising activities, all organised by the participants, to help generate as much cash as possible.
Head of General Medicine, Dan Coombes, supported by a selection of the people who took part on the day, was thrilled to present the cheque to the charity’s head of corporate partnerships, Nick Appleby, at Bayer’s offices in Green Park.
Nick Appleby presented a certificate of achievement and took the opportunity to talk to the team about the latest work the charity is doing, spelling out why donations such as this are so appreciated.
“By supporting Together for Short Lives you are making a difference to families across the UK supported by their local children’s hospice,” he told the group. “Raising £26,000 through this event is a fantastic achievement and means you have raised nearly £60,000 in the last two years. This equates to nearly 2,500 hours of direct care in children’s hospices. It makes a huge difference to a great number of children and families. The impact is massive so thank you!”
Dan Coombes said: “We are very proud to support this charity. As a healthcare organisation we support a lot of therapy areas, and it’s fantastic to be able to help a charity which specifically supports children and their families. It’s something that really motivates our team, especially those who were attempting a triathlon for the first time!”
Notes to editors:
Bayer: Science For A Better Life
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2016, the Group employed around 115,200 people and had sales of EUR 46.8 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.7 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.com.
Bayer media team: 0118 206 3000
Sara Bartlett: 07787 571020
Bayer’s offices in the UK and Ireland are located in Reading (head office), Cambridge and Dublin. For more information, go to www.bayer.co.uk
Follow us on Twitter at: www.twitter.com/UKBayer
Follow us on Facebook www.facebook.com/UKBayer
Follow us on YouTube at: www.youtube.com/BayerUKIre
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conformthem to future events or developments.